HIF
Hypoxia inducible factors (HIFs) are heterodimeric proteins belonging to the basic helix-loop-helix-PAS (bHLH/PAS) family of transcription factors that mediate the primary transcriptional response to stress caused by hypoxia (accessible O2 level < 2%). HIFs are characterized by containing two subunits, including O2-labile α subunit (HIFα) and constitutively expressed β subnit (HIFβ). Mammalian HIFα consists of three isoforms, including HIF1α, HIF2α and HIF3α, which play an essential role in the regulation of HIF activity by O2 availability. Under normal O2 tension, HIFα is hydroxylated at the two conserved proline residues within the O2-dependent degradation (ODD) domain by prolylhydroxylase domain proteins (PHDs) and undergoes proteosomal degradation catalyzed by a complex formed by E3 ubiquitin ligase and the von Hippel-Lindau protein (pVHL); while, under hypoxia, HIFα stabilizes with PHDs being deactivated and hence induce transcription of genes with adaptive functions.
Products for HIF
- Cat.No. Product Name Information
-
GC69794
(Rac)-Arnebin 1
(Rac)-β,β-Dimethylacrylalkannin; (Rac)-β,β-?Dimethylacrylshikonin
(Rac)-Arnebin 1 is the racemic form of β,β-Dimethylacrylalkannin and/or β,β-Dimethylacrylshikonin. These compounds are naphthoquinones isolated from plants in the Lithospermum genus, with β,β-Dimethylacrylshikonin exhibiting anti-tumor activity.
-
GC65133
(S,R,S)-AHPC-C5-COOH
VH032-C5-COOH
(S,R,S)-AHPC-C5-COOH (VH032-C5-COOH) is a synthesized?E3 ligase ligand-linker conjugate, contains the VH032 VHL-based ligand and a linker to form PROTACs. VH-032 is a selective and potent inhibitor of VHL/HIF-1α interaction with a Kd of 185 nM, has the potential for the study of anemia and ischemic diseases. -
GC61949
1,4-DPCA ethyl ester
1,4-DPCA ethyl ester is the ethyl ester of 1,4-DPCA and can inhibit factor inhibiting HIF (FIH).
-
GC16195
2,4-DPD
2,4-Diethylpyridine dicarboxylate
Diethyl pyridine-2,4-dicarb is a potent prolyl 4-hydroxylase-directed proinhibitor. -
GC15084
2-Methoxyestradiol (2-MeOE2)
2Hydroxyestradiol 2methyl ether, 2ME2, NSC 659853, Panzem
2-Methoxyestradiol (2-MeOE2/2-Me) is an HIF-1α inhibitor. -
GC14282
3-acetyl-11-keto-β-Boswellic Acid
3-O-acetyl-11-keto-β-Boswellic acid,AKBA
3-acetyl-11-keto-β-Boswellic Acid (Acetyl-11-keto-β-boswellic acid) is an active triterpenoid compound from the extract of Boswellia serrate and a novel Nrf2 activator. -
GC35230
Acetylarenobufagin
Acetylarenobufagin is a steroidal hypoxia inducible factor-1 (HIF-I) modulator.
-
GC32083
Acriflavine
Acriflavine is a fluorescent dye for labeling high molecular weight RNA.
-
GC62354
Acriflavine hydrochloride
Acriflavine hydrochloride (Acriflavinium chloride hydrochloride) is a fluorescent acridine dye that can be used to label nucleic acid.
-
GC12487
Adaptaquin
HIF prolyl hydroxylase inhibitor
HIF-prolyl hydroxylase-2 (PHD2) inhibitor -
GC33416
AFP464
NSC710464 free base
AFP464 (NSC710464 free base), is an active HIF-1α inhibitor with an IC50 of 0.25 μM, also is a potent aryl hydrocarbon receptor (AhR) activator. -
GC73864
AFP464 dihydrochloride
NSC710464 dihydrochloride
AFP464 (didrochloride) (NSC710464 (didrochloride)) is the drochloride form of AFP464 and is a potent HIF-1α inhibitor with an IC50 value of 0.25 μM. -
GC62277
AKB-6899
Ro24-7429 is a potent and orally active HIV-1 transactivator protein Tat antagonist. Ro24-7429 is also a runt-related transcription factor 1 (RUNX1) inhibitor. Ro24-7429 has anti-HIV, antifibrotic and anti-inflammatory effects.
-
GC42785
Amifostine (hydrate)
Ethyol, WR 2721
Amifostine (hydrate) (WR2721 trihydrate) is a broad-spectrum cytoprotective agent and a radioprotector. Amifostine (hydrate) selectively protects normal tissues from damage caused by radiation and chemotherapy. Amifostine (hydrate) is potent hypoxia-inducible factor-α1 (HIF-α1) and p53 inducer. Amifostine (hydrate) protects cells from damage by scavenging oxygen-derived free radicals. Amifostine (hydrate) reduces renal toxicity and has antiangiogenic action. -
GC12698
BAY 87-2243
A HIF-1 inhibitor,potent and selective
-
GC70471
BNS
BNS is a cell penetrant, potent and selective PHD2 (prolyl-hydroxylase 2) inhibitor.
-
GC17405
Chetomin
NSC 289491
An inhibitor of HIF signaling -
GN10518
Chitosamine hydrochloride
D-(+)-Glucosamine, GlcN, NSC 234443, NSC 758
-
GN10308
Chlorogenic acid
3OCaffeoylquinic acid, Heriguard, NSC 407296
Chlorogenic acid is a potent neuroprotective agent and also has antiviral,antifungal antioxidant and antitumor properties. CGA is also involved in regulating glucose and lipid metabolism and improving insulin sensitivity. -
GC74310
Cyclo(CKLIIF) TFA
Cyclo CKLIIF is a dual inhibitor for poxia inducible factor (HIF) 1 and 2, with affinity for HIF1-α and HIF2-α PAS-B domains KD of 2.6 and 2.2 μM, respectively.
-
GC16647
Daprodustat(GSK1278863)
GSK1278863
Daprodustat(GSK1278863) (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease. -
GC68955
Deferoxamine
Deferoxamine (Deferoxamine B) is an iron chelator (binding Fe(III) and many other metal cations), widely used to reduce the accumulation and deposition of iron in tissues.
-
GC31230
Dencichin (Dencichine)
Dencichin is a non-protein amino acid originally extracted from Panax notoginseng, and can inhibit HIF-prolyl hydroxylase-2 (PHD-2) activity.
-
GC38767
Deoxyshikonin
A natural products with anti-tumor activity
-
GC32449
Desidustat
P 1560, β-Zearalanol, β-Zearanol
An inhibitor of HIF-PH -
GC73945
DYB-03
DYB-03 is an oral active HIF-1α/EZH2 inhibitor.
-
GC18236
Echinomycin
Antibiotic A 654I; NSC 13502; NSC 526417; Quinomycin A; SK 302B
An inhibitor of HIF1mediated gene transcription -
GC33043
EL-102
EL-102 is a hypoxia-induced factor 1 (Hif1α) inhibitor. EL-102 induces apoptosis, inhibits tubulin polymerisation and shows activities against prostate cancer. EL-102 can be used for the research of cancer.
-
GC33634
Enarodustat (JTZ-951)
JTZ-951
Enarodustat (JTZ-951) is a potent and orally active hypoxia-inducible factor prolyl hydroxylase inhibitor, with an EC50 of 0.22 μM. -
GC33170
ENMD-119 (ENMD 1198)
IRC-110160
ENMD-119 (ENMD 1198) (IRC-110160), an orally active microtubule destabilizing agent, is a 2-methoxyestradiol analogue with antiproliferative and antiangiogenic activity. ENMD-119 (ENMD 1198) is suitable for inhibiting HIF-1alpha and STAT3 in human HCC cells and leads to reduced tumor growth and vascularization. -
GC61669
Ethyl 3,4-dihydroxybenzoate
Ethyl 3,4-dihydroxybenzoate (Ethyl protocatechuate), an antioxidant, is a prolyl-hydroxylase inhibitor found in the testa of peanut seeds.
-
GC13139
FG-4592 (ASP1517)
ASP1517, FG-4592
FG-4592, as an oral bioavailable hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, can promote coordinated erythropoiesis through HIF-mediated transcription.
-
GC16638
FG2216
IOX3, YM-311
HIF-prolyl hydroxylase inhibitor -
GC50537
FM19G11
A HIF α-subunit inhibitor
-
GC38044
Fraxinellone
-
GC30263
Glucosamine (D-Glucosamine)
Glucosamine (D-Glucosamine) (D-Glucosamine (D-Glucosamine)) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, is used as a dietary supplement.
-
GN10669
Glucosamine sulfate
-
GC34595
GN44028
A HIF-1 inhibitor
-
GC40918
Gramicidin A
Gramicidin A is a peptide component of gramicidin, an antibiotic mixture originally isolated from B.
-
GC39146
HIF-1 inhibitor-1
An inhibitor of HIF-1 signaling
-
GC66464
HIF-1α-IN-2
HIF-1α-IN-2 is an effective HIF-1α inhibitor with anticancer potencies (IC50s of 28 nM and 15 nM in MDA-MB-231 and MiaPaCa-2 cells, respectively). HIF-1α-IN-2 suppresses HIF-1α expression by blocking transcription and protein translation.
-
GC72867
HIF-1α-IN-2 hydrochloride
HIF-1α-IN-2 drochloride is an effective HIF-1α inhibitor with anticancer potencies (IC50s of 28 nM and 15 nM in MDA-MB-231 and MiaPaCa-2 cells, respectively).
-
GC73346
HIF-1α-IN-4
HIF-1α-IN-4 is a HIF-1α inhibitor with an IC50 value of 24 nM (in HEK293T cell).
-
GC73347
HIF-1α-IN-5
HIF-1α-IN-5 is a HIF-1α inhibitor with an IC50 value of 24 nM (in HEK293T cell).
-
GC73339
HIF-1/2α-IN-2
HIF-1/2α-IN-2 is an inhibitor of HIF-1/2α.
-
GC69226
HIF-2α agonist 2
HIF-2α agonist 2 (compound 10) is a HIF-2α activator with an EC50 value of 1.68 μM at a dose of 20 μM. HIF-2α agonist 2 has no cytotoxicity on 786-O-HRE-Luc cells. It can be used for oxygen metabolism research.
-
GC62584
HIF-2α-IN-2
HIF-2α-IN-2 is a hypoxia-inducible factors (HIF-2α) inhibitor extracted from patent WO2015035223A1, Compound 232, has an IC50 of 16 nM in scintillation proximity assay (SPA).
-
GC62418
HIF-2α-IN-3
HIF-2α-IN-3, an allosteric inhibitor of hypoxia inducible factor-2α (HIF-2α), exhibits an IC50 of 0.4 μM and a KD of 1.1 μM. Anticancer agent.
-
GC63678
HIF-2α-IN-4
HIF-2α-IN-4 is a potent inhibitor of hypoxia inducible factor-2α (HIF-2α) translation, with an IC50 of 5 μM. HIF-2α-IN-4 decreases both constitutive and hypoxia-induced HIF-2α protein expression. HIF-2α-IN-4 links its 5'UTR iron-responsive element to oxygen sensing.
-
GC69225
HIF-2α-IN-8
HIF-2α-IN-8 is an effective orally active inhibitor of HIF2α with IC50 values of 9, 37, and 246 nM for HIF2α SPA, HIF2α iScript, and HIF2α HRE RGA respectively. It has anti-tumor activity.
-
GC31358
HIF-2α-IN-1
HIF-2α-IN-1 is a HIF-2α inhibitor has an IC50 of less than 500 nM in HIF-2α scintillation proximity assay.
-
GC69227
HIF-IN-1
HIF-IN-1 (Compound 3c) is a hypoxia-inducible factor (HIF-1) inhibitor. HIF-IN-1 inhibits the aggregation of HIF-1α protein without affecting the level of HIF-1α mRNA. HIF-IN-1 has no significant cytotoxicity.
-
GC67941
HIF-PHD-IN-1
-
GC65570
HIF1-IN-3
HIF1-IN-3 (compound F4) is a potent HIF1 inhibitor with an EC50 value of 0.9 μM. HIF1-IN-3 can be used for researching anticancer.
-
GC11767
Hydralazine HCl
1-Hydrazinophthalazine
Hydralazine HCl is a orally active antihypertensive agent, reduces peripheral resistance directly by relaxing the smooth muscle cell layer in arterial vessel. -
GC60919
Hydroxycitric acid tripotassium hydrate
Hydroxycitric acid tripotassium hydrate (Potassium citrate monohydrate) is the major active ingredient of Garcinia cambogia.
-
GC32948
IDF-11774
A novel HIF-1 inhibitor
-
GC13018
IOX2(Glycine)
A selective PHD2 inhibitor
-
GC12255
IOX4
PHD2 inhibitor
-
GC73813
IOX5
IOX5 is a selective prolyl droxylases (PHD) inhibitor.
-
GC63828
Izilendustat
Izilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lα) and hypoxia inducible factor-2 (HIF-2).
-
GC15379
JNJ-42041935
HIF-PHD Inhibitor II
Hypoxia-inducible factor (HIF) prolyl hydroxylase (PHD) inhibitor -
GC13141
KC7F2
An inhibitor of HIF-1a protein synthesis
-
GC32724
LW6 (HIF-1α inhibitor)
Hypoxia-Inducible Factor1α Inhibitor
LW6 is a hypoxia-inducing factor 1(HIF) inhibitor, which effectively inhibits HIF-1α accumulation by degrading HIF-1α, but does not affect HIF-1A mRNA level during hypoxia. -
GC64945
M1001
M1001 is a weak hypoxia-inducible factor-2α (HIF-2α) agonist. M1001 can bind to the HIF-2α PAS-B domain, with a Kd of 667 nM. M1001 can be used in chronic kidney disease research.
-
GC65046
M1002
M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors.
-
GC19251
MK-8617
MK-8617 is an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) with an IC50 of 1 nM for PHD2.
-
GC14319
ML 228
CID-46742353
A HIF pathway activator -
GC10046
Molidustat (BAY85-3934)
Molidustat
Molidustat (BAY85-3934) (BAY 85-3934) is a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) with mean IC50 values of 480 nM for PHD1, 280 nM for PHD2, and 450 nM for PHD3. -
GC62406
Moracin O
Moracin O is a 2-arylbenzofuran isolated from the Mori Cortex Radicis.
-
GC69488
Moracin P
Moracin P is a 2-arylbenzofuran isolated from Mori Cortex Radicis. It exhibits strong in vitro inhibitory activity against hypoxia-inducible factor (HIF-1). Moracin P reduces the production of reactive oxygen species (ROS) induced by oxygen-glucose deprivation (OGD). Moracin P has neuroprotective and anti-inflammatory effects.
-
GC17358
Octyl-α-ketoglutarate
α-KG octyl ester
prolyl hydroxylases (PHD) activator -
GC12821
Oltipraz
NSC 347901, RP 35972
Nrf2 activator;An antischistosomal agent -
GC41625
Oroxylin A
6-Methoxybaicalein
Oroxylin A is a flavonoid that has been found in S.
-
GN10452
Paeoniflorin
NSC 178886
-
GC64584
PHD-1-IN-1
PHD-1-IN-1 is an orally active and potent HIF prolylhydroxylase domain-1 (PHD-1) inhibitor with an IC50 of 0.034 μM.
-
GC41572
PRLX-93936
PRLX-93936 is an analog of erastin that has antitumor activity.
-
GC72899
PRLX-93936 dihydrochloride
PRLX-93936 didrochloride (Compound 16) is a HIF-1α inhibitor with anticancer activity.
-
GC32680
PT-2385
PT-2385 is a selective HIF-2α inhibitor with a Ki of less than 50 nM.
-
GC65333
PT2399
PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-2α PAS B domain with an IC50 of 6 nM. PT2399 displays potent antitumor activity in vivo.
-
GC37034
PT2977
PT2977; MK-6482
PT2977 (PT2977) is an orally active and selective HIF-2α inhibitor with an IC50 of 9 nM. PT2977, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile. PT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC). -
GC15594
PX 12
IV-2
An irreversible inhibitor of thioredoxin-1 -
GC11031
PX-478 2HCl
PX-478 is a selective inhibitor that suppresses constitutive and hypoxia-induced HIF-1α levels.
-
GC37066
Rac-PT2399
A potent and specific HIF-2α inhibitor
-
GC49190
Roxadustat-d5
An internal standard for the quantification of roxadustat
-
GC69956
Steppogenin
Steppogenin is an effective inhibitor of HIF-1α and DLL4, with IC50 values of 0.56 and 8.46 μM, respectively. Steppogenin can be used for research on angiogenesis-related diseases such as solid tumors.
-
GC32876
SYP-5
A HIF-1 inhibitor
-
GC50211
TAT-cyclo-CLLFVY
Selective HIF-1 dimerization inhibitor
-
GC50128
TC-S 7009
High affinity and selective HIF-2α inhibitor
-
GC32945
THS-044
THS-044 binding stabilizes the HIF2α PAS-B folded state, for regulating HIF2 activity in endogenous and clinical settings.
-
GC32228
Tilorone dihydrochloride
NSC 143969
An interferon-inducing antiviral agent -
GC40555
Tiopronin
BRN 1859822, (±)-Tiopronin
Tiopronin is an antioxidant that has diverse biological activities. -
GC91083
Tiopronin-Cysteine Disulfide
A metabolite of tiopronin
-
GC49062
Tiopronin-d3
(±)-Tiopronin-d3
An internal standard for the quantification of tiopronin -
GC37801
TM6089
TM6089 is a unique Prolyl Hydroxylase (PHD) inhibitor which stimulates HIF activity without iron chelation and induces angiogenesis and exerts organ protection against ischemia.
-
GC31498
TP0463518
TP0463518 is a potent hypoxia-inducible factor prolyl hydroxylases (PHDs) inhibitor
-
GC64001
TRC160334
TRC160334 is a hypoxia-inducible factor (HIF) hydroxylase inhibitor.
-
GC16811
Vadadustat
AKB6548, PG-1016548
HIF-PH inhibitor -
GC37889
VCE-004.8
VCE-?004.8
VCE-004.8 (VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist. -
GC61863
Verucopeptin
Verucopeptin is a potent?HIF-1 (IC50=0.22 μM) inhibitor and decreases the expression of HIF-1 target genes and HIF-1α protein levels. Verucopeptin strongly inhibits v-ATPase activity?by directly targeting the v-ATPase ATP6V1G subunit but not ATP1V1B2 or ATP6V1D. Verucopeptin exhibits antitumor activity against multidrug resistance (MDR)?cancers and can be used for cancer research.